Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) was founded in 2009, formerly known as Ikaria Development LLC, and changed its current name in 2014. Headquartered in Hampton, New Jersey, Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) has 20 full-time employees. It is a company focusing on the treatment and research of cardiorespiratory diseases.
The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
Bellerophon Therapeutics (BLPH)
Bellerophon Therapeutics is a clinical therapeutic drug company, which is committed to developing cross products of drugs and equipment for the treatment of heart and lung diseases.The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
Brillofon Treatment Company provides INOperate, a pulsed nitric oxide delivery device, which is currently in phase III clinical trial (2019) for the treatment of pulmonary hypertension;The product has completed the Phase II clinical trial for the treatment of chronic obstructive pulmonary disease related to idiopathic pulmonary fibrosis and pulmonary hypertension related to pulmonary hypertension.The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
Bellerophon products are also used for other pulmonary hypertension symptoms.The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
Bellerophon treats Bellerophon Therapeutics (BLPH) US stock inflation:
BLPH was listed on the NASDAQ Exchange on February 14, 2015, with an issue price of US $12.The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
In May 2024, by opening an account at American Stock House and merging 10000 Hong Kong dollars (HKD) into Long Bridge, you can get a lifetime free commission of [Hong Kong shares+American shares], and can also get up to 1100 Hong Kong dollars of stock certificates+an additional 88 yuanJD.COMCard (exclusive)+RMB 100 rebate (exclusive).Exclusive to American Stock House customers.Click to view details!
The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.htmlThe article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks-https://www.mg21.com/blph.html
two hundred and forty-nine million three hundred and forty-two thousand five hundred and nineteen
WeChat official account: Encyclopedia of US and Hong Kong stocks
WeChat search: mggbkqs
mggbkqs
This article is written byOriginated by American Stock HousePublished at 20:55:34 on April 19, 2015
Original articles of American Stock House,Unauthorized reproduction is strictly prohibited。This article and all articles on this website are intended for information dissemination and sharing, and do not constitute an invitation, solicitation, suggestion, opinion or any guarantee for any securities, financial products or instruments. American Stock House does not endorse any companies, securities firms or financial products.There are risks in investment. Customers should weigh the risks they can bear and make investment judgments independently. If you have any questions, please consult independent professionals.Disclaimer
American stock biotechnology company
The first day of listing falls below the issue price
